Prostate, Phase III

Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.

Ages
18 years and older
Gender
Male only

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Michael Hurwitz

michael.hurwitz@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Michael Hurwitz, MD, PhD
Associate Professor of Internal Medicine (Medical Oncology)

Sub-Investigators

Last Updated
03/04/2025
Study HIC
#2000023885